Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases - Wikidata - awgldk - TriplyDB

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

http://www.wikidata.org/entity/Q28067408

about

Long-Term Survival According to Histology and Radiologic Response to Preoperative Chemotherapy in 126 Patients Undergoing Resection of Non-GIST Sarcoma Liver Metastases.Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol.

P2860

Q47633053-4379BE53-36A3-48A1-96ED-4F092A2868F1 Q48146966-888CC354-D0A2-4C81-A025-8BB4E203ABCE

P2860

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

http://www.wikidata.org/entity/Q28067408

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

@ast

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

@en

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

@nl

type

label

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

@ast

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

@en

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

@nl

prefLabel

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

@ast

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

@en

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

@nl

P1433

Q28067408-AEE8286D-1E02-4CB6-9ADB-D448B57259F7

P1476

Q28067408-8E263D18-F86E-4670-AAF1-360539386A7D

P2093

Q28067408-0E6AF099-D650-4A18-967C-68C4ED7DC126

Q28067408-1D4EB37A-AB1F-44CB-866E-5EBACA0203BF

Q28067408-397901AA-9947-450B-A26C-4E76C07A3968

Q28067408-764D2061-7A95-4306-82BC-CCBE89DDD0C2

Q28067408-A6753C7B-CD8E-463D-902D-FC4CAEEEADA9

P2860

Q28067408-065EAC98-3542-407A-A858-D511B3EC653E

Q28067408-07F2FD35-D832-4880-A797-B35C0CF8FFA2

Q28067408-08560896-4C09-4C64-8AFE-18A2797CA9B0

Q28067408-09B90EEA-42F7-4A36-8200-F999C0924F91

Q28067408-0BC7E0B9-4343-4E41-902A-62BC66F316BE

Q28067408-1A318016-F37D-43F5-88C9-798889265D28

Q28067408-2AF8AA2C-EBE8-4FB2-98A7-BBD4FB2293F0

Q28067408-2C4B1A0B-1186-4FFB-AF74-E91777D67BCD

Q28067408-2DDF0144-0837-4851-8E2C-556102AC6394

Q28067408-2F6EBD24-6253-4746-A28D-F868E2FB0BD2

P304

Q28067408-37E9A695-3DC7-40DF-BB04-A4EDC2481FF2

P31

Q28067408-FB9E53DB-A580-413E-8E60-37DC31202662

P356

Q28067408-8CB18E2D-CCC3-42CC-A58A-C8A8B6E60612

P407

Q28067408-415849F6-3E73-4141-B768-084566095610

P433

Q28067408-2A7216F7-E862-4E60-83A8-501DF8C57A7B

P478

Q28067408-B7BEA7A0-4EC7-494C-8381-D9C91E4CECBB

P50

Q28067408-998F8160-6562-4357-BE88-DBC79D2C0B12

Q28067408-FFB68093-3D07-4910-8AC3-2583B93D9B0D

P577

Q28067408-47015629-2D23-403C-A871-ACA8985EE825

P698

Q28067408-F6FF4E08-52A3-44FD-9FEE-97FA8C465309

P921

Q28067408-AD4FD40E-EAB4-467B-80D8-B83C89DF50F9

P932

Q28067408-223E439D-0F5B-4864-AB29-A7CFDA062616

P356

P1433

P1476

Recent Advances in Chemotherapy and Surgery for Colorectal Liver Metastases

@en

P2093

Felice Giuliante

http://www.w3.org/2001/XMLSchema#string

Giuseppe Zimmitti

http://www.w3.org/2001/XMLSchema#string

Guillaume Passot

http://www.w3.org/2001/XMLSchema#string

Olivier Soubrane

http://www.w3.org/2001/XMLSchema#string

Suguru Yamashita

http://www.w3.org/2001/XMLSchema#string

P2860

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system.

Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

P304

72-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000449349

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Nicolas Vauthey

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27995091

http://www.w3.org/2001/XMLSchema#string

P921

P932

5159720

http://www.w3.org/2001/XMLSchema#string